Molly C. McCloskey

629 total citations
23 papers, 336 citations indexed

About

Molly C. McCloskey is a scholar working on Molecular Biology, Parasitology and Neurology. According to data from OpenAlex, Molly C. McCloskey has authored 23 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Parasitology and 6 papers in Neurology. Recurrent topics in Molly C. McCloskey's work include Parasitic Infections and Diagnostics (6 papers), Barrier Structure and Function Studies (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Molly C. McCloskey is often cited by papers focused on Parasitic Infections and Diagnostics (6 papers), Barrier Structure and Function Studies (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Molly C. McCloskey collaborates with scholars based in United States, Switzerland and Denmark. Molly C. McCloskey's co-authors include James L. McGrath, Matthew A. Hulverson, Lynn K. Barrett, Ryan Choi, Kayode K. Ojo, Grant R. Whitman, Thomas R. Gaborski, Alec T. Salminen, Richard E. Waugh and Dustin J. Maly and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Molly C. McCloskey

23 papers receiving 336 citations

Peers

Countries citing papers authored by Molly C. McCloskey

Since Specialization

Citations

This map shows the geographic impact of Molly C. McCloskey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly C. McCloskey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly C. McCloskey more than expected).

Fields of papers citing papers by Molly C. McCloskey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly C. McCloskey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly C. McCloskey. The network helps show where Molly C. McCloskey may publish in the future.

Co-authorship network of co-authors of Molly C. McCloskey

This figure shows the co-authorship network connecting the top 25 collaborators of Molly C. McCloskey. A scholar is included among the top collaborators of Molly C. McCloskey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly C. McCloskey. Molly C. McCloskey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An automated platform for simultaneous, longitudinal analysis of engineered neuromuscular tissues for applications in neurotoxin potency testing 2025 ·Current Research in Toxicology ·J. W. Fleming, Molly C. McCloskey, (unknown), David R. Nash, Vincent Leung, (unknown), (unknown), Christopher Cavanaugh, Julie Mathieu, (unknown), Mark Bothwell, David L. Mack, Nicholas A. Geisse, Alec S.T. Smith	1
2	Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier 2024 ·Journal of Visualized Experiments ·Molly C. McCloskey, (unknown), (unknown), (unknown), (unknown), Kai-Hua Chen, Thomas R. Gaborski, Britta Engelhardt, James L. McGrath	2
3	Pericytes Enrich the Basement Membrane and Reduce Neutrophil Transmigration in an In Vitro Model of Peripheral Inflammation at the Blood–Brain Barrier 2024 ·Biomaterials Research ·Molly C. McCloskey, (unknown), (unknown), (unknown), Benjamin D. Gastfriend, Eric V. Shusta, Sean P. Palecek, Britta Engelhardt, Thomas R. Gaborski, Jonathan Flax, Richard E. Waugh, James L. McGrath	8
4	Modelling a Human Blood-Brain Barrier Co-Culture Using an Ultrathin Silicon Nitride Membrane-Based Microfluidic Device 2023 ·International Journal of Molecular Sciences ·(unknown), Molly C. McCloskey, Sandra Vergo, Søren Christensen, James L. McGrath, Morten S. Nielsen	7
5	The Modular µSiM: A Mass Produced, Rapidly Assembled, and Reconfigurable Platform for the Study of Barrier Tissue Models In Vitro 2022 ·Advanced Healthcare Materials ·Molly C. McCloskey, (unknown), (unknown), (unknown), Kaihua Chen, (unknown), (unknown), Hideaki Nishihara, (unknown), Vinay V. Abhyankar, Stefano Begolo, Benjamin H. Singer, Kevin F. Webb, Katsuo Kurabayashi, Jonathan Flax, Richard E. Waugh, Britta Engelhardt, James L. McGrath	21
6	A tissue chip with integrated digital immunosensors: In situ brain endothelial barrier cytokine secretion monitoring 2022 ·Biosensors and Bioelectronics ·(unknown), Yujing Song, Andrew Stephens, (unknown), Molly C. McCloskey, James L. McGrath, Anuska V. Andjelkovic, Benjamin H. Singer, Katsuo Kurabayashi	26
7	Molecular mechanisms underlying the heterogeneous barrier responses of two primary endothelial cell types to sphingosine-1-phosphate 2022 ·European Journal of Cell Biology ·Alec T. Salminen, Molly C. McCloskey, (unknown), (unknown), Kaihua Chen, William J. Houlihan, (unknown), Jonathan Flax, Richard E. Waugh, James L. McGrath	4
8	Sourcing cells for in vitro models of human vascular barriers of inflammation 2022 ·SHILAP Revista de lepidopterología ·Molly C. McCloskey, (unknown), (unknown), (unknown), (unknown), Hani A. Awad, James L. McGrath	4
9	The Modular µSiM Reconfigured: Integration of Microfluidic Capabilities to Study In Vitro Barrier Tissue Models under Flow 2022 ·Advanced Healthcare Materials ·(unknown), (unknown), (unknown), Molly C. McCloskey, (unknown), Thomas R. Gaborski, Richard E. Waugh, James L. McGrath, Steven W. Day, Vinay V. Abhyankar	17
10	Rapid and specific detection of intact viral particles using functionalized microslit silicon membranes as a fouling-based sensor 2021 ·The Analyst ·(unknown), (unknown), Alec T. Salminen, Molly C. McCloskey, (unknown), Brian M. Ward, Jonathan Flax, James L. McGrath	4
11	In vitro Studies of Transendothelial Migration for Biological and Drug Discovery 2020 ·Frontiers in Medical Technology ·Alec T. Salminen, Zahra Allahyari, Shayan Gholizadeh, Molly C. McCloskey, (unknown), (unknown), Thomas R. Gaborski, James L. McGrath	28
12	Microvascular Mimetics for the Study of Leukocyte–Endothelial Interactions 2020 ·Cellular and Molecular Bioengineering ·Tejas S. Khire, Alec T. Salminen, (unknown), (unknown), Molly C. McCloskey, (unknown), Henry H. Chung, Thomas R. Gaborski, Richard E. Waugh, Angela Glading, James L. McGrath	18
13	Endothelial cell apicobasal polarity coordinates distinct responses to luminally versus abluminally delivered TNF-α in a microvascular mimetic 2020 ·Integrative Biology ·Alec T. Salminen, Jeffrey Tithof, (unknown), Elysia A. Masters, Molly C. McCloskey, Thomas R. Gaborski, Douglas H. Kelley, Anthony P. Pietropaoli, Richard E. Waugh, James L. McGrath	16
14	Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy 2019 ·Journal of Medicinal Chemistry ·Wenlin Huang, Matthew A. Hulverson, Ryan Choi, Samuel L.M. Arnold, Zhongsheng Zhang, Molly C. McCloskey, Grant R. Whitman, Robert C. Hackman, Kasey Rivas, Lynn K. Barrett, Kayode K. Ojo, Wesley C. Van Voorhis, Erkang Fan	23
15	7H-Pyrrolo[2,3-d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1H-Pyrazolo[3,4-d]pyrimidin-4-amine-Based Inhibitors 2018 ·ACS Infectious Diseases ·Rama Subba Rao Vidadala, Martin Golkowski, Matthew A. Hulverson, Ryan Choi, Molly C. McCloskey, Grant R. Whitman, Wenlin Huang, Samuel L.M. Arnold, Lynn K. Barrett, Erkang Fan, E.A. Merritt, Wesley C. Van Voorhis, Kayode K. Ojo, Dustin J. Maly	4
16	Screening of the Pathogen Box for inhibitors with dual efficacy against Giardia lamblia and Cryptosporidium parvum 2018 ·PLoS neglected tropical diseases ·Kelly M. Hennessey, (unknown), (unknown), Matthew A. Hulverson, Ryan Choi, Molly C. McCloskey, Grant R. Whitman, Lynn K. Barrett, E.A. Merritt, Alexander R. Paredez, Kayode K. Ojo	31
17	Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis 2018 ·The Journal of Infectious Diseases ·Matthew A. Hulverson, Igor Bruzual, (unknown), Wenlin Huang, Rama Subba Rao Vidadala, Ryan Choi, Samuel L.M. Arnold, Grant R. Whitman, Molly C. McCloskey, Lynn K. Barrett, Kasey Rivas, (unknown), Amy E. DeRocher, Marilyn Parsons, Kayode K. Ojo, Dustin J. Maly, Erkang Fan, Wesley C. Van Voorhis, J. Stone Doggett	11
18	5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvum 2017 ·Antimicrobial Agents and Chemotherapy ·Wenlin Huang, Ryan Choi, Matthew A. Hulverson, Zhongsheng Zhang, Molly C. McCloskey, Deborah A. Schaefer, Grant R. Whitman, Lynn K. Barrett, Rama Subba Rao Vidadala, Michael W. Riggs, Dustin J. Maly, Wesley C. Van Voorhis, Kayode K. Ojo, Erkang Fan	12
19	Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection 2017 ·The Journal of Infectious Diseases ·Samuel L.M. Arnold, Ryan Choi, Matthew A. Hulverson, Deborah A. Schaefer, Sumiti Vinayak, Rama Subba Rao Vidadala, Molly C. McCloskey, Grant R. Whitman, Wenlin Huang, Lynn K. Barrett, Kayode K. Ojo, Erkang Fan, Dustin J. Maly, Michael W. Riggs, Boris Striepen, Wesley C. Van Voorhis	33
20	Research Article: The influence of acetylcholinesterase on anxiety- and depression-like behaviors in fluoxetine-treated male mice 2017 ·BIOS ·Molly C. McCloskey, (unknown), Shawn Anderson	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact